TrialBone marrow transplantation2022

Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01.

Francesca Bonifazi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.